Megaphages harbor mini-Cas proteins ideal for gene editing

While the DNA-cutting proteins central to Jennifer Doudna’s CRISPR-Cas9 and related gene-editing tools originally came from bacteria, a newfound variety of Cas proteins apparently evolved in viruses that infect bacteria.

What it’s like to pivot a health startup in a pandemic

In early March, YourChoice Therapeutics CEO Akash Bakshi was typing out his investor update when he tucked in a question at the bottom. His company’s progress toward using niclosamide, a medication normally used to treat tapeworms, as a new kind of birth control that stopped sperm from moving was going well — the startup had…

UC Berkeley launches trial of saliva test for COVID-19

Scientists from Jennifer Doudna’s Innovative Genomics Institute (IGI), the same UC Berkeley group that rapidly opened up a pop-up COVID-19 testing laboratory in March, are now testing a quicker and cost-efficient way to obtain patient samples through saliva.